vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and TOMPKINS FINANCIAL CORP (TMP). Click either name above to swap in a different company.
TOMPKINS FINANCIAL CORP is the larger business by last-quarter revenue ($194.8M vs $185.2M, roughly 1.1× AMICUS THERAPEUTICS, INC.). TOMPKINS FINANCIAL CORP runs the higher net margin — 49.4% vs 0.9%, a 48.5% gap on every dollar of revenue. On growth, TOMPKINS FINANCIAL CORP posted the faster year-over-year revenue change (152.7% vs 23.7%). TOMPKINS FINANCIAL CORP produced more free cash flow last quarter ($31.9M vs $16.0M). Over the past eight quarters, TOMPKINS FINANCIAL CORP's revenue compounded faster (63.6% CAGR vs 29.5%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Tompkins Financial Corporation is a small, diversified financial services company based in Ithaca, New York. It is the parent of the Tompkins Trust Company, as well as several other banks, an insurance agency, and a wealth management division.
FOLD vs TMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $194.8M |
| Net Profit | $1.7M | $96.2M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | 71.7% |
| Net Margin | 0.9% | 49.4% |
| Revenue YoY | 23.7% | 152.7% |
| Net Profit YoY | -88.5% | 388.9% |
| EPS (diluted) | $0.00 | $6.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $194.8M | ||
| Q3 25 | $169.1M | $87.4M | ||
| Q2 25 | $154.7M | $82.6M | ||
| Q1 25 | $125.2M | $81.7M | ||
| Q4 24 | $149.7M | $77.1M | ||
| Q3 24 | $141.5M | $76.6M | ||
| Q2 24 | $126.7M | $72.7M | ||
| Q1 24 | $110.4M | $72.8M |
| Q4 25 | $1.7M | $96.2M | ||
| Q3 25 | $17.3M | $23.7M | ||
| Q2 25 | $-24.4M | $21.5M | ||
| Q1 25 | $-21.7M | $19.7M | ||
| Q4 24 | $14.7M | $19.7M | ||
| Q3 24 | $-6.7M | $18.6M | ||
| Q2 24 | $-15.7M | $15.7M | ||
| Q1 24 | $-48.4M | $16.9M |
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — | ||
| Q1 24 | 87.7% | — |
| Q4 25 | 8.6% | 71.7% | ||
| Q3 25 | 20.3% | 35.6% | ||
| Q2 25 | -6.1% | 34.2% | ||
| Q1 25 | -6.3% | 31.6% | ||
| Q4 24 | 10.7% | 33.4% | ||
| Q3 24 | 15.3% | 32.0% | ||
| Q2 24 | 11.8% | 28.3% | ||
| Q1 24 | -25.1% | 30.4% |
| Q4 25 | 0.9% | 49.4% | ||
| Q3 25 | 10.2% | 27.1% | ||
| Q2 25 | -15.8% | 26.0% | ||
| Q1 25 | -17.3% | 24.1% | ||
| Q4 24 | 9.8% | 25.5% | ||
| Q3 24 | -4.8% | 24.3% | ||
| Q2 24 | -12.4% | 21.6% | ||
| Q1 24 | -43.9% | 23.2% |
| Q4 25 | $0.00 | $6.72 | ||
| Q3 25 | $0.06 | $1.65 | ||
| Q2 25 | $-0.08 | $1.50 | ||
| Q1 25 | $-0.07 | $1.37 | ||
| Q4 24 | $0.05 | $1.39 | ||
| Q3 24 | $-0.02 | $1.30 | ||
| Q2 24 | $-0.05 | $1.10 | ||
| Q1 24 | $-0.16 | $1.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $132.8M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $938.4M |
| Total Assets | $949.9M | $8.7B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $132.8M | ||
| Q3 25 | $263.8M | $193.5M | ||
| Q2 25 | $231.0M | $212.6M | ||
| Q1 25 | $250.6M | $193.1M | ||
| Q4 24 | $249.9M | $134.4M | ||
| Q3 24 | $249.8M | $132.3M | ||
| Q2 24 | $260.1M | $70.9M | ||
| Q1 24 | $239.6M | $57.1M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $938.4M | ||
| Q3 25 | $230.4M | $788.8M | ||
| Q2 25 | $204.3M | $761.8M | ||
| Q1 25 | $193.6M | $741.4M | ||
| Q4 24 | $194.0M | $713.4M | ||
| Q3 24 | $178.8M | $719.9M | ||
| Q2 24 | $132.5M | $674.6M | ||
| Q1 24 | $130.7M | $667.9M |
| Q4 25 | $949.9M | $8.7B | ||
| Q3 25 | $868.8M | $8.5B | ||
| Q2 25 | $815.3M | $8.4B | ||
| Q1 25 | $789.8M | $8.2B | ||
| Q4 24 | $785.0M | $8.1B | ||
| Q3 24 | $786.6M | $8.0B | ||
| Q2 24 | $749.5M | $7.9B | ||
| Q1 24 | $721.8M | $7.8B |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $38.9M |
| Free Cash FlowOCF − Capex | $16.0M | $31.9M |
| FCF MarginFCF / Revenue | 8.6% | 16.4% |
| Capex IntensityCapex / Revenue | 0.2% | 3.6% |
| Cash ConversionOCF / Net Profit | 9.62× | 0.40× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $105.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $38.9M | ||
| Q3 25 | $35.7M | $34.9M | ||
| Q2 25 | $-26.5M | $18.9M | ||
| Q1 25 | $7.8M | $22.2M | ||
| Q4 24 | $-3.9M | $95.0M | ||
| Q3 24 | $-23.0M | $21.2M | ||
| Q2 24 | $22.7M | $27.3M | ||
| Q1 24 | $-29.7M | $23.2M |
| Q4 25 | $16.0M | $31.9M | ||
| Q3 25 | $35.3M | $33.9M | ||
| Q2 25 | $-28.9M | $18.3M | ||
| Q1 25 | $7.5M | $20.9M | ||
| Q4 24 | $-4.2M | $88.8M | ||
| Q3 24 | $-23.3M | $18.9M | ||
| Q2 24 | $21.6M | $26.3M | ||
| Q1 24 | $-31.5M | $21.9M |
| Q4 25 | 8.6% | 16.4% | ||
| Q3 25 | 20.9% | 38.8% | ||
| Q2 25 | -18.7% | 22.1% | ||
| Q1 25 | 6.0% | 25.5% | ||
| Q4 24 | -2.8% | 115.1% | ||
| Q3 24 | -16.5% | 24.7% | ||
| Q2 24 | 17.0% | 36.2% | ||
| Q1 24 | -28.5% | 30.0% |
| Q4 25 | 0.2% | 3.6% | ||
| Q3 25 | 0.2% | 1.1% | ||
| Q2 25 | 1.6% | 0.8% | ||
| Q1 25 | 0.2% | 1.7% | ||
| Q4 24 | 0.2% | 8.1% | ||
| Q3 24 | 0.3% | 2.9% | ||
| Q2 24 | 0.9% | 1.3% | ||
| Q1 24 | 1.6% | 1.9% |
| Q4 25 | 9.62× | 0.40× | ||
| Q3 25 | 2.06× | 1.47× | ||
| Q2 25 | — | 0.88× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | -0.27× | 4.82× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.74× | ||
| Q1 24 | — | 1.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
TMP
Segment breakdown not available.
